Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Cited by (1,000)

Items 101–200 of 1,000

1. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
   Spielman, Lindsay Joy, Gibson, Deanna Lynn, Klegeris, Andis · 2018 · Neurochemistry International
2. Non‐classical exocytosis of α‐synuclein is sensitive to folding states and promoted under stress conditions
   Jang, Ara, Lee, He‐Jin, Suk, Ji‐Eun, Jung, Jin‐Woo, Kim, Kwang‐Pyo, Lee, Seung‐Jae · 2010 · Journal of Neurochemistry
3. α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
   Eun-Jung Lee, Moon-Sook Woo, Pyong‐Gon Moon, Moon‐Chang Baek, In-Young Choi, Won-Ki Kim, Eunsung Junn, Hee-Sun Kim · 2010 · The Journal of Immunology
4. Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
   Nolwen L. Rey, Géraldine H. Petit, Luc Bousset, Ronald Melki, Patrik Brundin · 2013 · Acta Neuropathologica
5. α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
   Isabel Lastres‐Becker, Ayşe Ulusoy, Nadia Giselle Innamorato, Gürdal Şahin, Alberto Rábano, Deniz Kirik, Antonio Cuadrado · 2012 · Human Molecular Genetics
6. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
   Zhang, Wei, Phillips, Kester, Wielgus, Albert R., Liu, Jie, Albertini, Alberto, Zucca, Fabio A., Faust, Rudolph, Qian, Steven Y., Miller, David S., Chignell, Colin F. et al. · 2011 · Neurotoxicity Research
7. Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
   Li Du, Ying Zhang, Yang Chen, Jie Zhu, Yi Yang, Hong-Liang Zhang · 2016 · Molecular Neurobiology
8. GBA Variants and Parkinson Disease: Mechanisms and Treatments
   Laura Smith, Anthony H.V. Schapira · 2022 · Cells
9. Microglia and neuroprotection: From in vitro studies to therapeutic applications
   Elisabetta Polazzi, Barbara Monti · 2010 · Progress in Neurobiology
10. Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia
    Nikhil Panicker, Souvarish Sarkar, Dilshan S. Harischandra, Matthew P Neal, Tae‐In Kam, Huajun Jin, Hariharan Saminathan, Monica Renee Langley, Adhithiya Charli, Manikandan Samidurai et al. · 2019 · The Journal of Experimental Medicine
11. Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
    Sandeep Vasant More, Hemant Kumar, In Su Kim, Soo-Yeol Song, Dong-Kug Choi · 2013 · Mediators of Inflammation
12. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
    Appel, Stanley H., Beers, David R., Henkel, Jenny S. · 2010 · Trends in Immunology
13. Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
    Sanchez-Guajardo, Vanesa, Febbraro, Fabia, Kirik, Deniz, Romero-Ramos, Marina · 2010 · PLoS ONE
14. Microglia in the developing brain: a potential target with lifetime effects
    Harry, G. Jean, Kraft, Andrew D. · 2012 · NeuroToxicology
15. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients
    Doorn, Karlijn J, Moors, Tim, Drukarch, Benjamin, van de Berg, Wilma DJ, Lucassen, Paul J, van Dam, Anne-Marie · 2014 · Acta Neuropathologica Communications
16. Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
    Kathryn A. Frankola, Nigel H. Greig, Weiming Luo, David Tweedie · 2011 · CNS & Neurological Disorders - Drug Targets
17. The Role of Lipids in Parkinson’s Disease
    Helena Xicoy, Bé Wieringa, Gerard J.M. Martens · 2019 · Cells
18. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
    Uchihara, Toshiki, Giasson, Benoit I. · 2016 · Acta Neuropathologica
19. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
    Aaron D. Thome, Ashley S. Harms, Laura A. Volpicelli‐Daley, David G. Standaert · 2016 · Journal of Neuroscience
20. Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
    Allen Reish, Heather E., Standaert, David G. · 2015 · Journal of Parkinson’s Disease
21. Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease
    Md. Ezazul Haque, Mahbuba Akther, Md. Jakaria, In‐Su Kim, Shofiul Azam, Dong‐Kug Choi · 2019 · Movement Disorders
22. Ageing and neurodegenerative diseases
    Chia-Wei Hung, Yu‐Chih Chen, Wan-Ling Hsieh, Shih‐Hwa Chiou, Chung-Lan Kao · 2010 · Ageing Research Reviews
23. Inflammation and Adaptive Immunity in Parkinson's Disease
    Rodney Lee Mosley, Jessica A.L. Hutter-Saunders, David K. Stone, Howard Eliot Gendelman · 2011 · Cold Spring Harbor Perspectives in Medicine
24. Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease
    Ashley D. Reynolds, Jason G. Glanzer, Irena Kadiu, Mary Ricardo-Dukelow, Anathbandhu Chaudhuri, Pawel S. Ciborowski, Ronald L. Cerny, Benjamin B. Gelman, Mark P. Thomas, Rodney Lee Mosley et al. · 2007 · Journal of Neurochemistry
25. Neurosteroids as regulators of neuroinflammation
    Canelif Yılmaz, Kanelina Karali, Georgia Fodelianaki, Achille Gravanis, Triantafyllos Chavakis, Ioannis Charalampopoulos, Vasileia Ismini Alexaki · 2019 · Frontiers in Neuroendocrinology
26. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein
    Melanie B. Watson, Franziska Richter, Soo‐Kyung Lee, Lauryn C. Gabby, Jennifer E. Wu, Eliezer Masliah, Rita B. Effros, Marie‐Françoise Chesselet · 2012 · Experimental Neurology
27. Tubulin Polymerization-promoting Protein (TPPP/p25α) Promotes Unconventional Secretion of α-Synuclein through Exophagy by Impairing Autophagosome-Lysosome Fusion
    Patrick Ejlerskov, Izabela Rasmussen, Troels T. Nielsen, Ann‐Louise Bergström, Yumi Tohyama, Poul Henning Jensen, Frederik Vilhardt · 2013 · Journal of Biological Chemistry
28. Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
    Carla M. Lema Tomé, Trevor Tyson, Nolwen L. Rey, Stefan A. Grathwohl, Markus Britschgi, Patrik Brundin · 2012 · Molecular Neurobiology
29. Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
    Vanesa Sánchez-Guajardo, Christopher J. Barnum, Malú G. Tansey, Marina Romero‐Ramos · 2013 · ASN NEURO
30. Microglia in the CNS: Immigrants from another world
    Marco Prinz, Alexander Mildner · 2010 · Glia
31. Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain
    Poonam Singh Thakur, Ludivine S. Breger, Martin Lundblad, Oi Wan Wan, Bengt Mattsson, Kelvin C. Luk, Virginia M.‐Y. Lee, John Q. Trojanowski, Anders Björklund · 2017 · Proceedings of the National Academy of Sciences
32. α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
    Klegeris, Andis, Pelech, Steven, Giasson, Benoit I., Maguire, John, Zhang, Hong, McGeer, Edith G., McGeer, Patrick L. · 2008 · Neurobiology of Aging
33. The changing phenotype of microglia from homeostasis to disease
    Xiaoguang Luo, Shengdi Chen · 2012 · Translational Neurodegeneration
34. Non-steroidal anti-inflammatory drugs in Parkinson's disease
    Ennio Esposito, Vincenzo Di Matteo, A Benigno, Massimo Pierucci, Giuseppe Crescimanno, Giuseppe Di Giovanni · 2007 · Experimental Neurology
35. Microglia in Parkinson's disease
    Ho, Margaret S. · 2019 · Advances in Experimental Medicine and Biology
36. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
    George, Sonia, Rey, Nolwen L., Tyson, Trevor, Esquibel, Corinne, Meyerdirk, Lindsay, Schulz, Emily, Pierce, Steven, Burmeister, Amanda R., Madaj, Zachary, Steiner, Jennifer A. et al. · 2019 · Molecular Neurodegeneration
37. Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
    Ji Wang, Fushun Wang, Dongmei Mai, Shaogang Qu · 2020 · Frontiers in Neuroscience
38. Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase
    Chéret, Cyril, Gervais, Annie, Lelli, Aurélia, Colin, Catherine, Amar, Lahouari, Ravassard, Philippe, Mallet, Jacques, Cumano, Ana, Krause, Karl-Heinz, Mallat, Michel · 2008 · The Journal of Neuroscience
39. Modulation of Brain Hemichannels and Gap Junction Channels by Pro-Inflammatory Agents and Their Possible Role in Neurodegeneration
    Juan Andres Orellana, Pablo José Sáez, Kenji F. Shoji, Kurt Alex Schalper, Nicolás Palacios‐Prado, Victoria Velarde, Christian Giaume, Michael V. L. Bennett, Juan Carlos Sáez · 2008 · Antioxidants and Redox Signaling
40. Alpha-Synuclein Function and Dysfunction on Cellular Membranes
    David Snead, David Eliezer · 2014 · Experimental Neurobiology
41. Parkinson’s disease as a result of aging
    Rodriguez, Manuel, Rodriguez‐Sabate, Clara, Morales, Ingrid, Sanchez, Alberto, Sabate, Magdalena · 2015 · Aging Cell
42. Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis
    Daniela Lecca, Yoo Jin Jung, Michael T. Scerba, Inho Hwang, Yu Kyung Kim, Sun Kim, Sydney Modrow, David Tweedie, Shih‐Chang Hsueh, Dong Liu et al. · 2022 · Alzheimer s & Dementia
43. Curcumin Ameliorates the Neurodegenerative Pathology in A53T α-synuclein Cell Model of Parkinson’s Disease Through the Downregulation of mTOR/p70S6K Signaling and the Recovery of Macroautophagy
    Tianfang Jiang, Yingjie Zhang, Haiyan Zhou, Hongmei Wang, Lipeng Tian, Jun Liu, Jianqing Ding, Shengdi Chen · 2013 · Journal of Neuroimmune Pharmacology
44. Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan
    Tuan Leng Tay, Catherine Béchade, Ivana D’Andrea, Marie‐Kim St‐Pierre, Mathilde S. Henry, Anne Roumier, Marie‐Ève Tremblay · 2018 · Frontiers in Molecular Neuroscience
45. Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
    Sara Almeida Ferreira, Marina Romero‐Ramos · 2018 · Frontiers in Cellular Neuroscience
46. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term
    Rey, Nolwen L., George, Sonia, Steiner, Jennifer A., Madaj, Zachary, Luk, Kelvin C., Trojanowski, John Q., Lee, Virginia M.-Y., Brundin, Patrik · 2018 · Acta Neuropathologica
47. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases
    Hui‐Ming Gao, Hui Zhou, Jau‐Shyong Hong · 2012 · Trends in Pharmacological Sciences
48. Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
    Hazel Hall‐Roberts, David R. Brown · 2015 · Biomolecules
49. Inflammation in the early stages of neurodegenerative pathology
    Preeti J. Khandelwal, Alexander M. Herman, Charbel Moussa · 2011 · Journal of Neuroimmunology
50. Endocannabinoid system in neurodegenerative disorders
    Balapal S. Basavarajappa, Madhu Shivakumar, Vikram Joshi, Shivakumar Subbanna · 2017 · Journal of Neurochemistry
51. Interactive role of the toll‐like receptor 4 and reactive oxygen species in LPS‐induced microglia activation
    Liya Qin, Guorong Li, Xun Qian, Yuxin Liu, Xuefei Wu, Bin Liu, Jau‐Shyong Hong, Michelle L. Block · 2005 · Glia
52. Neuroinflammation in the living brain of Parkinson's disease
    Yasuomi Ouchi, Shunsuke Yagi, Masamichi Yokokura, Masanobu Sakamoto · 2009 · Parkinsonism & Related Disorders
53. A Macrophage−Nanozyme Delivery System for Parkinson's Disease
    Elena V. Batrakova, Shu Li, Ashley D. Reynolds, Rodney Lee Mosley, Tatiana K. Bronich, Alexander V. Kabanov, Howard Eliot Gendelman · 2007 · Bioconjugate Chemistry
54. Biological role of Toll-like receptor-4 in the brain
    Teresa Trotta, Chiara Porro, Rosa Calvello, Maria Antonietta Panaro · 2014 · Journal of Neuroimmunology
55. Microglia as modulators of exosomal alpha-synuclein transmission
    Yun Fei Xia, Guoxin Zhang, Chao Han, Kai Ma, Xingfang Guo, Fang Jung Wan, Liang Kou, Sijia Yin, Ling Liu, Jinsha Huang et al. · 2019 · Cell Death and Disease
56. Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases
    Brkic, Marjana, Balusu, Sriram, Libert, Claude, Vandenbroucke, Roosmarijn E. · 2015 · Mediators of Inflammation
57. NADPH oxidase as a therapeutic target in Alzheimer's disease
    Michelle L. Block · 2008 · BMC Neuroscience
58. Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
    Sumit Sarkar, James B. Raymick, Syed Z. Imam · 2016 · International Journal of Molecular Sciences
59. Glia and alpha-synuclein in neurodegeneration: A complex interaction
    Dominik Brück, Gregor Karl Wenning, Nadia Stefanova, Lisa Fellner · 2015 · Neurobiology of Disease
60. M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?
    Mark S. Moehle, Andrew B. West · 2014 · Neuroscience
61. Metabolic reprogramming and polarization of microglia in Parkinson’s disease: Role of inflammasome and iron
    Haiyang Yu, Qing Chang, Tong Sun, Xin He, Lulu Wen, Jing An, Juan Feng, Yuhong Zhao · 2023 · Ageing Research Reviews
62. Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
    Min S. Wang, Shanta P. Boddapati, Sharareh Emadi, Michael R. Sierks · 2010 · BMC Neuroscience
63. α-Synuclein Alters Toll-Like Receptor Expression
    Dawn Béraud, Margaret A. Twomey, Benjamin Bloom, Andrew Mittereder, Vy Ton, Katherine Neitzke, Sergey Chasovskikh, Timothy R. Mhyre, Kathleen A. Maguire‐Zeiss · 2011 · Frontiers in Neuroscience
64. Inflammation in Parkinson's Disease
    Kemal Uğur Tüfekçi, Ralph Leo Johan Meuwissen, Şermin Genç, Kürşad Genç · 2012 · Advances in protein chemistry and structural biology
65. Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
    Minjeong Park, Sang‐Myung Cheon, Hye-Ran Bae, Sang-Ho Kim, Jae Woo Kim · 2011 · Journal of Clinical Neurology
66. Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
    Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, Federico De Marco, Adele Romano, Silvana Gaetani · 2017 · Frontiers in Neuroscience
67. Lipopolysaccharide Animal Models for Parkinson's Disease
    Mei Liu, Guoying Bing · 2011 · Parkinson s Disease
68. Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation
    Zhijie Qin, Dongmei Hu, Shubo Han, Stephen H. Reaney, Donato A. Di Monte, Anthony L. Fink · 2006 · Journal of Biological Chemistry
69. Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
    Troncoso-Escudero, Paulina, Parra, Alejandra, Nassif, Melissa, Vidal, Rene L. · 2018 · Frontiers in Neurology
70. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
    Tapan Behl, Gagandeep Kaur, Aayush Sehgal, Shaveta Bhardwaj, Sukhbir Singh, Camelia Liana Buhaș, Claudia Teodora Judea Pusta, Diana Uivaroșan, Mihai Alexandru Munteanu, SIMONA GABRIELA BUNGAU · 2021 · International Journal of Molecular Sciences
71. Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
    Rommy von Bernhardi M., Jaime L. Eugenín · 2011 · Antioxidants and Redox Signaling
72. Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
    Bruna Araújo, Rita Caridade-Silva, Carla Soares-Guedes, Joana Martins‐Macedo, Eduardo D. Gomes, Susana Monteiro, Fábio Gabriel Teixeira · 2022 · Cells
73. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies
    Mathieu Bourdenx, Nikolaos Stavros Koulakiotis, Despina Sanoudou, Erwan Bézard, Benjamin Dehay, Anthony Tsarbopoulos · 2015 · Progress in Neurobiology
74. Targets for neuroprotection in Parkinson's disease
    Talene A. Yacoubian, David G. Standaert · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
75. A review of the mechanisms of cone degeneration in retinitis pigmentosa
    Daniel S. Narayan, John P. M. Wood, Glyn Chidlow, Robert James Casson · 2016 · Acta Ophthalmologica
76. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
    Krashia, Paraskevi, Cordella, Alberto, Nobili, Annalisa, La Barbera, Livia, Federici, Mauro, Leuti, Alessandro, Campanelli, Federica, Natale, Giuseppina, Marino, Gioia, Calabrese, Valeria et al. · 2019 · Nature Communications
77. Therapeutic approaches to inflammation in neurodegenerative disease
    Andis Klegeris, Edith G. McGeer, Patrick L. McGeer · 2007 · Current Opinion in Neurology
78. Autoantibodies to alpha‐synuclein in inherited Parkinson’s disease
    Katerina K. Papachroni, Natalia N. Ninkina, Angeliki Papapanagiotou, Georgios M. Hadjigeorgiou, Georgia Xiromerisiou, Alexandros Papadimitriou, Anastasios Kalofoutis, Vladimir L. Buchman · 2006 · Journal of Neurochemistry
79. Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes
    Rannikko, Emmy H., Weber, Stephanie S., Kahle, Philipp J. · 2015 · BMC Neuroscience
80. Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
    Adelin Gustot, José Ignacio Gallea, Rabia Sarroukh, M. Soledad Celej, Jean‐Marie Ruysschaert, Vincent Raussens · 2015 · Biochemical Journal
81. Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
    Spielman, Lindsay J., Little, Jonathan P., Klegeris, Andis · 2014 · Journal of Neuroimmunology
82. Genome-wide association study confirms extant PD risk loci among the Dutch
    Javier Simón‐Sánchez, Jacobus Johannes van Hilten, Bart P.C. van de Warrenburg, Bart Post, Henk W. Berendse, Sampath Arepalli, Dena G. Hernandez, Rob M. A. de Bie, Daan C. Velseboer, Hans Scheffer et al. · 2011 · European Journal of Human Genetics
83. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
    Corinna Bliederhaeuser, Veselin Grozdanov, Anna Speidel, Lisa Zondler, Wolfgang Philipp Ruf, Hanna Bayer, Martin Kiechle, Marisa S. Feiler, Axel Freischmidt, David Brenner et al. · 2015 · Acta Neuropathologica
84. Alpha-synuclein spreading in Parkinson’s disease
    Ariadna Recasens, Benjamin Dehay · 2014 · Frontiers in Neuroanatomy
85. α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease
    Zachary A. Sorrentino, Benoit I. Giasson, Paramita Chakrabarty · 2019 · Acta Neuropathologica
86. Astrocyte-derived GDNF is a potent inhibitor of microglial activation
    Sandra M. Rocha, Ana Clara Cristóvão, Filipa Lopes Campos, Carla P. Fonseca, Graça Baltazar · 2012 · Neurobiology of Disease
87. Effects of inflammation on stem cells: together they strive?
    Çağhan Kızıl, Nikos Kyritsis, Michael Brand · 2015 · EMBO Reports
88. Immune system responses in Parkinson's disease: Early and dynamic
    Malú G. Tansey, Marina Romero‐Ramos · 2018 · European Journal of Neuroscience
89. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson’s disease model
    Neha Sharma, Bimla Nehru · 2017 · Inflammopharmacology
90. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
    Hughes, Craig D., Choi, Minee L., Ryten, Mina, Hopkins, Lee, Drews, Anna, Botía, Juan A., Iljina, Maria, Rodrigues, Margarida, Gagliano, Sarah A., Gandhi, Sonia et al. · 2019 · Acta Neuropathologica
91. NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease
    Haslund‐Vinding, J, McBean, G, Jaquet, V, Vilhardt, F · 2017 · British Journal of Pharmacology
92. Antioxidant gene therapy against neuronal cell death
    Juliana Navarro-Yepes, Laura Mireya Zavala-Flores, Annadurai Anandhan, Fang Wang, Maciej Skotak, Namas Chandra, Ming Li, Aglaia Pappa, Daniel Martínez‐Fong, Luz María Del Razo et al. · 2013 · Pharmacology & Therapeutics
93. How is alpha‐synuclein cleared from the cell?
    Leonidas Stefanis, Evangelia Emmanouilidou, Marina Pantazopoulou, Deniz Kirik, Kostas Vekrellis, George K. Tofaris · 2019 · Journal of Neurochemistry
94. Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
    Dawn Béraud, Hannah A. Hathaway, Jordan Trecki, Sergey Chasovskikh, Delinda A. Johnson, Jeffrey Allan Johnson, Howard J. Federoff, Mika Shimoji, Timothy R. Mhyre, Kathleen A. Maguire‐Zeiss · 2012 · Journal of Neuroimmune Pharmacology
95. Neuroinflammation in Parkinson’s Disease
    Jae‐Kyung Lee, Thi Anh Thu Tran, Malú G. Tansey · 2009 · Journal of Neuroimmune Pharmacology
96. The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments
    Vanesa Sánchez-Guajardo, Noémie Tentillier, Marina Romero‐Ramos · 2015 · Neuroscience
97. Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
    María Teresa Ibarra-Gutiérrez, Norma Serrano‐García, Marisol Orozco‐Ibarra · 2023 · Molecular Neurobiology
98. Intercellular (Mis)communication in Neurodegenerative Disease
    Gwenn A. Garden, Albert R. La Spada · 2012 · Neuron
99. The role of inflammation in sporadic and familial Parkinson’s disease
    Michela Deleidi, Thomas Gasser · 2013 · Cellular and Molecular Life Sciences
100. Copper induces microglia-mediated neuroinflammation through ROS/NF-κB pathway and mitophagy disorder
     Qian Zhou, Ying Zhang, Lu Lu, Hu Zhang, Chao Zhao, Yuepu Pu, Lihong Yin · 2022 · Food and Chemical Toxicology